These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 21134539)

  • 1. Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer.
    Hughes DT; White ML; Miller BS; Gauger PG; Burney RE; Doherty GM
    Surgery; 2010 Dec; 148(6):1100-6; discussion 1006-7. PubMed ID: 21134539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The need of prophylactic central lymph node dissection is controversial in terms of postoperative thyroglobulin follow-up of patients with cN0 papillary thyroid cancer.
    Korkmaz MH; Öcal B; Saylam G; Çakal E; Bayır Ö; Tutal E; Tatar EÇ
    Langenbecks Arch Surg; 2017 Mar; 402(2):235-242. PubMed ID: 28224278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical response to radioactive iodine therapy for prophylactic central neck dissection is not superior to total thyroidectomy alone in cN0 patients with papillary thyroid cancer.
    Lin B; Qiang W; Wenqi Z; Tianyu Y; Lina Z; Bin J
    Nucl Med Commun; 2017 Dec; 38(12):1036-1040. PubMed ID: 28953211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Level VI lymph node dissection does not decrease radioiodine uptake in patients undergoing radioiodine ablation for differentiated thyroid cancer.
    Yoo D; Ajmal S; Gowda S; Machan J; Monchik J; Mazzaglia P
    World J Surg; 2012 Jun; 36(6):1255-61. PubMed ID: 22430670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications.
    So YK; Seo MY; Son YI
    Surgery; 2012 Feb; 151(2):192-8. PubMed ID: 21497873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
    Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
    J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of total thyroidectomy with therapeutic central and lateral neck dissection with a single dose of radioiodine in the treatment of regionally advanced papillary thyroid cancer and effects on serum thyroglobulin.
    Hughes DT; Miller BS; Cohen MS; Doherty GM; Gauger PG
    Ann Surg Oncol; 2014 May; 21(5):1647-52. PubMed ID: 24385210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer.
    Sywak M; Cornford L; Roach P; Stalberg P; Sidhu S; Delbridge L
    Surgery; 2006 Dec; 140(6):1000-5; discussion 1005-7. PubMed ID: 17188149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter cohort study of total thyroidectomy and routine central lymph node dissection for cN0 papillary thyroid cancer.
    Popadich A; Levin O; Lee JC; Smooke-Praw S; Ro K; Fazel M; Arora A; Tolley NS; Palazzo F; Learoyd DL; Sidhu S; Delbridge L; Sywak M; Yeh MW
    Surgery; 2011 Dec; 150(6):1048-57. PubMed ID: 22136820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment.
    Bonnet S; Hartl D; Leboulleux S; Baudin E; Lumbroso JD; Al Ghuzlan A; Chami L; Schlumberger M; Travagli JP
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1162-7. PubMed ID: 19116234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of size of lymph node metastasis on postsurgical stimulated thyroglobulin levels after prophylactic unilateral central neck dissection in papillary thyroid carcinoma.
    Lang BH; Tang AH; Wong KP; Shek TW; Wan KY; Lo CY
    Ann Surg Oncol; 2012 Oct; 19(11):3472-8. PubMed ID: 22565664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of postoperative radioactive iodine scans in patients who underwent prophylactic central lymph node dissection.
    Laird AM; Gauger PG; Miller BS; Doherty GM
    World J Surg; 2012 Jun; 36(6):1268-73. PubMed ID: 22270997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of routine unilateral central neck dissection on preablative and postablative stimulated thyroglobulin levels after total thyroidectomy in papillary thyroid carcinoma.
    Lang BH; Wong KP; Wan KY; Lo CY
    Ann Surg Oncol; 2012 Jan; 19(1):60-7. PubMed ID: 21681379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of prophylactic central compartment neck dissection in the treatment of clinically node-negative papillary thyroid cancer patients.
    Gambardella C; Tartaglia E; Nunziata A; Izzo G; Siciliano G; Cavallo F; Mauriello C; Napolitano S; Thomas G; Testa D; Rossetti G; Sanguinetti A; Avenia N; Conzo G
    World J Surg Oncol; 2016 Sep; 14(1):247. PubMed ID: 27644091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic central neck dissection for papillary thyroid cancer.
    Barczyński M; Konturek A; Stopa M; Nowak W
    Br J Surg; 2013 Feb; 100(3):410-8. PubMed ID: 23188784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.
    Hughes DT; Laird AM; Miller BS; Gauger PG; Doherty GM
    Ann Surg Oncol; 2012 Sep; 19(9):2951-7. PubMed ID: 22526913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis.
    Xu S; Huang H; Huang Y; Qian J; Wang X; Xu Z; Liu S; Liu J
    JAMA Surg; 2023 Jan; 158(1):73-79. PubMed ID: 36449303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge of pathologically versus clinically negative lymph nodes is associated with reduced use of radioactive iodine post-thyroidectomy for low-risk papillary thyroid cancer.
    Ruel E; Thomas S; Dinan MA; Perkins JM; Roman SA; Sosa JA
    Endocrine; 2016 Jun; 52(3):579-86. PubMed ID: 26708045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical lymph node metastasis in papillary thyroid microcarcinoma: a study of 551 resections.
    So YK; Son YI; Hong SD; Seo MY; Baek CH; Jeong HS; Chung MK
    Surgery; 2010 Sep; 148(3):526-31. PubMed ID: 20189620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of intraoperative determination of central node metastasis by the surgeon in papillary thyroid carcinoma.
    Ji YB; Lee DW; Song CM; Kim KR; Park CW; Tae K
    Otolaryngol Head Neck Surg; 2014 Apr; 150(4):542-7. PubMed ID: 24429357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.